Variant report
Variant | esv17337 |
---|---|
Chromosome Location | chr5:16974643-16978522 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373945274 | chr5:16974645-16974646 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs545628317 | chr5:16974680-16974681 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183439049 | chr5:16974723-16974724 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs186950439 | chr5:16974727-16974728 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs554358733 | chr5:16974805-16974806 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192094315 | chr5:16974831-16974832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370879042 | chr5:16974856-16974857 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376362487 | chr5:16974867-16974868 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs146768819 | chr5:16974868-16974869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs77163689 | chr5:16974880-16974881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs77555537 | chr5:16974882-16974883 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565134664 | chr5:16974949-16974950 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532350306 | chr5:16974963-16974964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186757636 | chr5:16975026-16975027 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs79021356 | chr5:16975037-16975038 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562680056 | chr5:16975069-16975070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529785192 | chr5:16975082-16975083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547871036 | chr5:16975130-16975131 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10059183 | chr5:16975191-16975192 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs191368134 | chr5:16975254-16975255 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs527254624 | chr5:16975255-16975256 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs182095459 | chr5:16975298-16975299 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs187053372 | chr5:16975353-16975354 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs76297573 | chr5:16975361-16975362 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531759008 | chr5:16975371-16975372 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566728375 | chr5:16975429-16975430 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192826633 | chr5:16975464-16975465 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs569426697 | chr5:16975480-16975481 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536791301 | chr5:16975515-16975516 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555052575 | chr5:16975518-16975519 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs573281651 | chr5:16975537-16975538 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs540594766 | chr5:16975565-16975566 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs117970431 | chr5:16975576-16975577 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs565224010 | chr5:16975600-16975601 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs544478774 | chr5:16975683-16975684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532261012 | chr5:16975701-16975702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs562581735 | chr5:16975740-16975741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs529834901 | chr5:16975774-16975775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs547200202 | chr5:16975825-16975826 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs541535781 | chr5:16975918-16975919 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs565504209 | chr5:16975928-16975929 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs559782676 | chr5:16976014-16976015 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148068905 | chr5:16976051-16976052 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551784347 | chr5:16976062-16976063 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs570414045 | chr5:16976077-16976078 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs547912130 | chr5:16976094-16976095 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs141774175 | chr5:16976115-16976116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs113709178 | chr5:16976182-16976183 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73066866 | chr5:16976183-16976184 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs536800612 | chr5:16976187-16976188 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 21364760 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Lung cancer | 16740712 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Melanoma | 22183965 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:16970600-16975000 | Weak transcription | Right Atrium | heart |
2 | chr5:16971000-16983200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr5:16971800-16976200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr5:16972400-16976000 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
5 | chr5:16973800-16976000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr5:16974600-16975600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr5:16975800-16977000 | Enhancers | GM12878-XiMat | blood |
8 | chr5:16976000-16977000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
9 | chr5:16976000-16977000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr5:16976200-16977000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr5:16976400-16977000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
12 | chr5:16977000-16980600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
13 | chr5:16977000-16982000 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
14 | chr5:16977000-16983200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |